Design of experiments: Concept and applications of plackett burman design

Clinical Research and Regulatory Affairs

Volumn 24, Issue 1, 2007, Pages 1-23

  Vanaja, K ^a   Rani, R H Shobha ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Design of Experiments; Plackett Burman; Screening Design; Statistical Designs

Indexed keywords

ANALYTIC METHOD; MEDICAL LITERATURE; RANDOMIZATION; REVIEW; SCREENING; STATISTICAL ANALYSIS;

EID: 34249744715     PISSN: 10601333     EISSN: 15322521     Source Type: Journal    
DOI: 10.1080/10601330701220520     Document Type: Review

References (54)

1. http://www.mathscareers.org.uk (accessed September 2006).
2. Jacquez JA. Design of Experiments. Pergamon 1998; 3358(2): 259-279.
3. Decaestecker TN, Lambert WE, Peteghem Carlos HV, Deforce D, Van Bocxlaer JF. Optimization of solid-phase extraction for a liquid chromatographic-tandem mass spectrometric general unknown screening procedure by means of computational techniques. J Chrom A 2004; 1056: 57-65.
4. http://www.doesinc.com/knowledge.htm (accessed September 2006).
5. Myers RW. Response Surface Methodology. In: Encyclopedia of Biopharmaceutical Statistics. Taylor and Francis, 2003: 858-869.
6. Webb TS, Bauer KW Kr. Comparison of analysis strategies for screening designs in large-scale computer simulation models, Proceedings of the Winter Simulation Conference, Tew JD, Mannivannan S, Sadowski DA, Seila AF, Eds, 1994: 305-311.
7. Murphy RJ. Screening design. In: Encyclopedia of Biopharmaceutical Statistics. Taylor and Francis, 2003: 920.
8. Trocine L, Malone CL. Finding important independent variables through screening designs: A comparison of methods, Proceedings of the Winter Simulation ConferenceJoines JA, Barton RR, Kang K, Fishwick PA, Eds, 2000: 749-754.
9. http://www.itl.nist.gov/div898/handbook (accessed June, 2006).
10. Prvan T, Street DJ. An annotated bibliography of application papers using certain classes of fractional factorial and related designs. J Stat Plan Inf 2002; 245-269.
11. Wass JA. Formal experimental design and analysis for immunochemical product development. Part I. IVD Technology Magazine 1997, September.
12. Nijhuis A, van der Knaap HCM, Jond SDE, Vandeginste BGM. Strategy for ruggedness tests in chromatographic method validation. Anal chim Acta 1999; 391: 187-202.
13. Plackett RL and Burman JP. The design of optimum multifactorial experiments. Biometrika 1946; 33:305-325.
14. Yannis LL. A Plackett-Burnam screening design directs the efficient formulation of multicomponent DRV liposomes. J Pharm Biomed Anal 2001; 26: 255-263.
15. Leeuwen van JA. Vandeginste BGM, Kateman M, Mulholland, Cleland A. An expert system for the choice of factors for a ruggedness test in liquid chromatography. Anal Chim Acta 1990; 228: 145-153.
16. Heyden YV, Questier F, Massart DL. A ruggedness test strategy for procedure related factors: experimental set-up and interpretation. J Pharm Biomed Anal 1998; 17: 153-168.
17. Heyden YV, Luypaert K, Hartmann C, Massart DL, Hoogmartens J, Beer DJ. Ruggedness tests on the High Performance Liquid Chromatography ass of the United States Pharmacoepia XXII for tetracycline hydrochloride. A comparison of experimental designs and statistical interpretations. Anal Chim Acta 1995; 312: 245-262.
18. Goupy Jacques. What kind of experimental design for finding and checking robustness of analytical methods? Anal Chim Acta 2005; 544: 184-190.
19. http://DFSS for Thermal Management Screening DoEs.htm (accessed September 2006).
20. http://www.fda.gov/cber/guidelines.htm (accessed January 2007).
21. Weiyong L, David N, Henrik TR, Kudan P, Tridarsh S. Sample preparation optimization for assay of active pharmaceutical ingredients in a transdermal drug delivery system using experimental designs. J Pharm Biomed Anal 2005; 37: 493-498.
22. Vikas R, Kumar B, Dinesh G, Ashok KT. Sodium citrate cross-linked chitosan films:optimization as substitute for human/rat/rabbit epidermal sheets. J. Pharm Pharmaceut Sci 2005; 8(1): 10-17.
23. Sastry SV and Khan MA. Aqueous based polymeric dispersion: Plackett-Burman design for screening of formulation variables of Atenolol Gastrointestinal Therapeutic System. Pharm Acta Hel 1998; 73: 105-112.
24. Khan MA, Sastry SV, Vaithiyalingam SR, Agarwal V, Nazzal S, Reddy IK. Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: evaluation of main effects of several formulation variables. Int J Pharm 2000 Jan 5; 193(2): 147-56.
25. Rege BD, Gawel J, Kou JJ. Identification of critical process variables for coating actives onto tablets via statistically designed experiments. Int J Pharm 2002; 237: 87-94.
26. Siobanda W, Pillay v, Danckwerts MP, Viljoen AM, Vuuren SV and Riaz A. Experimental Design for the Formulation and Optimization of Novel Cross-Linked Oilispheres Developed for In Vitro Site-Specific Release of Mentha piperita Oil. AAPS PharmSciTech 2004; 5(1): 1-14.
27. Furlanetto S, Maestrelli F, Orlandini S, Pinzauti S, Mura P. Optimization of dissolution test precision for a ketoprofen oral extended-release product. J Pharm Biomed Anal 2003; 32: 159-65.
28. Zaghloul AA, Faltinek J, Vaithiyalingam SR, Reddy IK, Khan MA. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets. Pharmazie 2001 Apr; 56(4): 321-4.
29. Li JZ, Rekhi GS, Augsburger LL, Shangraw RF. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution. Pharm Dev Technol 1996 Dec; 1(4): 343-55.
30. Rakhi BS, Mohammad N, Indra KR, Mansoor AK. A Dual Controlled Gastrointestinal Therapeutic System of Salmon Calcitonin. II. Screening of Process and Formulation Variables. Clin Res Reg Aff 2004; 21(3-4): 231-238.
31. Anthony C, Kerryann S. Statistical Evaluation of Vial Design Features That Influence Sublimation Rates during Primary Drying. Pharm Res 2004; 21(3): 536-542.
32. Rodriguez JC, Barciela J, Garcia S, Herrero C, Pena RM. Optimization of two flow-injection spectrophotometric methods for the determination of indapamide in pharmaceutical dosage forms. J AOAC Int 2005; 88(4): 1148-54.
33. Dürig T and Fassihi AR. Identification of stabilizing and destabilizing effects of excipient-drug interactions in solid dosage form design. Int J Pharm 1993; 97(1-3): 161-170.
34. Rambali B, Baert L, Thone D, Massart DL. Using experimental design to optimize the process parameters in fluidized bed granulation. Drug Dev Ind Pharm. 2001 Jan; 27(1): 47-55.
35. Srisagul S. Application of Arrhenius Equation and Plackett-Burman Design to Ascorbic Acid Syrup Development. Naresuan University Journal 2004; 12 (2): 1-121.
36. Donald DH and Mumtaz S. Development and validation of HPLC stability indicating assays. In: Jens TC, Rhodes CT, Eds. Drug Stability, Principles and Practices. 3d ed Marcel Dekker, 2005: 329-384.
37. Nevado JJB, Cabanillas CG, Llerena MJV, Robledo VR. Enantiomeric determination, validation and robustness studies of racemic citalopram in pharmaceutical formulations by capillary electrophoresis. J Chrom A 200; 1072: 249-257.
38. Gotti R, Furlanetto V, Cavrini V, Pinzauti S. Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulfate. J Chrom A 2000; 875: 411-422.
39. Rogan, MM Altria KD and Goodall DM. Plackett-Burman experimental design in chiral analysis using capillary electrophoresis. Chromatographia 1994; 38(11-12): 723-729.
40. Predrag S, et al., Ruggedness testing of an HPLC method for the determination of ciprofloxacin 2005. J Serb Chem Soc; 70(7): 979-986.
41. Dejaegher B, Capron X, Smeyers-Verbeke J, Vander YH. Randomization tests to identify significant effects in experimental designs for robustness testing. Anal Chim Acta 2006; 564: 184-200.
42. Nguyen MNA, Tallieu L, Plaizier-Vercammen J, Massart DL, Vander HY. Validation of an HPLC method on short columns to assay ketoconazole and formaldehyde in shampoo. J Pharm Biomed Anal 2003; 32: 1-19.
43. De Spiegeleer BM, Sintobin K, Desmet J. High performance liquid chromatography stability study of malonyl-coenzyme A, using statistical experimental designs. Biomed Chromatogr 1989 Sep; 3(5): 213-6.
44. Li W, Rasmussen HT. Strategy for developing and optimizing liquid chromatography methods in pharmaceutical development using computer-assisted screening and Plackett-Burman experimental design. J Chromatogr A 2003 Oct 24; 1016(2): 165-80.
45. Vander HY, Hartmann C, Massart DL, Michel L, Kiechle P, Erni F. Ruggedness tests for a high-performance liquid chromatographic assay: comparison of an evaluation at two and three levels by using two-level Plackett-Burman designs. Anal Chim Acta 1995; 316: 15-26.
46. Weiyong L and Henrik TR. Strategy for developing and optimizing liquid chromatography methods in pharmaceutical development using computer-assisted screening and Plackett-Burman experimental design. J Chrom A 2003; 1016(2): 165-180.
47. Garrido-Lopez A, Tena MT. Experimental design approach for the optimisation of pressurised fluid extraction of additives from polyethylene films J Chromatogr A 2005 Dec 16; 1099(1-2): 75-83.
48. Reche F, Garrigos MC, Marin ML, Canto A, Jimenez A. Optimization of parameters for the supercritical fluid extraction in the determination of N-nitrosamines in rubbers. J Chrom A 2002; 963: 419-26.
49. Decaestecker TN, Lambert WE, Van Peteghem CH, Deforce D, Van Bocxlaer JF. Optimization of solid-phase extraction for a liquid chromatographic-tandem mass spectrometric general unknown screening procedure by means of computational techniques. J Chromatogr A 2004 Nov 12; 1056(1-2): 57-65.
50. Arambarri I, Lasa M, Garcia R, Millan E. Determination of fuel dialkyl ethers and BTEX in water using headspace solid-phase microextraction and gas chromatography-flame ionization detection. J Chromatogr A. 2004 Apr 16; 1033(2): 193-203.
51. Shahla M, Gunnar T, Bo K, Optimization of resolution in micellar electrokinetic chromatography by multivariate evaluation of electrolytes, J of Chrom A 2001; 907: 267-277.
52. Flores JR, Nevado JJB, Penalvo GC, Diez NM. Development of a Micellar electrokinetic capillary chromatography method for the determination of three drugs employed in the erectile dysfunction therapy. J Chrom B 2004; 811: 231-263.
53. Mikaeli S, Thorsen G, Karlberg B. Optimisation of resolution in micellar electrokinetic chromatography by multivariate evaluation of electrolutes. J Chromatogr A 2001 Jan 12; 907(1-2): 267-77.
54. http://www.fda.gov/CVM/guidance (accessed December 2006).